|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 March 2001, Vol. 97, No. 6, pp. 1776-1786
IMMUNOBIOLOGY
Enhanced immune activity of cytotoxic
T-lymphocyte epitope analogs derived from positional scanning synthetic
combinatorial libraries
Corinna La Rosa,
Radhika Krishnan,
Susan Markel,
Jonathan P. Schneck,
Richard Houghten,
Clemencia Pinilla, and
Don J. Diamond
From the Laboratory of Vaccine Research, Beckman
Research Institute, the City of Hope Medical Center, Duarte, CA; the
Torrey Pines Institute for Molecular Studies and Mixture Sciences Inc,
San Diego, CA; and the Department of Pathology, Johns Hopkins
University Medical Center, Baltimore, MD.
The pp65495-503 cytotoxic T-lymphocyte (CTL)
epitope from cytomegalovirus (CMV) is universally recognized among
CMV+ individuals who express an allele of the human
leukocyte antigen A (HLA-A*0201). The relative binding affinity of the
epitope to HLA-A*0201 is moderate, and its increased activity
might prove beneficial in its use as a CTL epitope vaccine. A new
approach to enhance the activity of T-cell epitopes is the use of
positional scanning synthetic combinatorial libraries (PS-SCLs). Using
a nonamer PS-SCL, the pp65495-503 epitope was modified
after screening a CMV-specific T-cell clone (TCC) (3-3F4) from
which the native peptide sequence was derived. Two peptides with amino
acid substitutions at P1, P3, P7, and P8 are between
103 and 104 more active than the native
epitope. Although the native CTL epitope terminates as a free acid,
both tetrasubstituted peptides only function as CTL epitopes when the
carboxyl terminus is amidated. Selective substitution of the native
sequence based on PS-SCL screening results identified 3 amidated
monosubstituted and disubstituted peptides that are better recognized
than the native epitope by TCCs from a cohort expressing HLA-A*0201. In
vitro stimulation of peripheral blood mononuclear cells with each of
the peptide epitope analogs stimulated memory CTLs, which
recognized CMV-infected targets among a high percentage of
CMV+ individuals. Binding studies of peptide analogs with
HLA-Ig (immunoglobulin) dimers and 2 different TCCs correlated with in
vitro lysis results. These data suggest that increasing the activity of
CTL epitopes while maintaining broad recognition is possible, which
holds promise for vaccine development in infectious disease and cancer.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Lustgarten, A. L. Dominguez, and C. Pinilla
Identification of Cross-Reactive Peptides Using Combinatorial Libraries Circumvents Tolerance against Her-2/neu-Immunodominant Epitope
J. Immunol.,
February 1, 2006;
176(3):
1796 - 1805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Krymskaya, M. C. Sharma, J. Martinez, W. Haq, E. C. Huang, A. P. Limaye, D. J. Diamond, and S. F. Lacey
Cross-Reactivity of T Lymphocytes Recognizing a Human Cytotoxic T-Lymphocyte Epitope within BK and JC Virus VP1 Polypeptides
J. Virol.,
September 1, 2005;
79(17):
11170 - 11178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Z. Wang, C. La Rosa, S. Mekhoubad, S. F. Lacey, M. C. Villacres, S. Markel, J. Longmate, J. D. I. Ellenhorn, R. F. Siliciano, C. Buck, et al.
Attenuated poxviruses generate clinically relevant frequencies of CMV-specific T cells
Blood,
August 1, 2004;
104(3):
847 - 856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Gibson, G. Piccinini, D. Lilleri, M. G. Revello, Z. Wang, S. Markel, D. J. Diamond, and K. Luzuriaga
Human Cytomegalovirus Proteins pp65 and Immediate Early Protein 1 Are Common Targets for CD8+ T Cell Responses in Children with Congenital or Postnatal Human Cytomegalovirus Infection
J. Immunol.,
February 15, 2004;
172(4):
2256 - 2264.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Daftarian, S. Ali, R. Sharan, S. F. Lacey, C. La Rosa, J. Longmate, C. Buck, R. F. Siliciano, and D. J. Diamond
Immunization with Th-CTL Fusion Peptide and Cytosine-Phosphate-Guanine DNA in Transgenic HLA-A2 Mice Induces Recognition of HIV-Infected T Cells and Clears Vaccinia Virus Challenge
J. Immunol.,
October 15, 2003;
171(8):
4028 - 4039.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. La Rosa, Z. Wang, J. C. Brewer, S. F. Lacey, M. C. Villacres, R. Sharan, R. Krishnan, M. Crooks, S. Markel, R. Maas, et al.
Preclinical development of an adjuvant-free peptide vaccine with activity against CMV pp65 in HLA transgenic mice
Blood,
November 15, 2002;
100(10):
3681 - 3689.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Lawendowski, G. M. Giurleo, Y. Y. Huang, G. J. Franklin, J. M. Kaplan, B. L. Roberts, and C. A. Nicolette
Solid-Phase Epitope Recovery: A High Throughput Method for Antigen Identification and Epitope Optimization
J. Immunol.,
September 1, 2002;
169(5):
2414 - 2421.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rubio-Godoy, C. Pinilla, V. Dutoit, E. Borras, R. Simon, Y. Zhao, J.-C. Cerottini, P. Romero, R. Houghten, and D. Valmori
Toward Synthetic Combinatorial Peptide Libraries in Positional Scanning Format (PS-SCL)-based Identification of CD8+ Tumor-reactive T-Cell Ligands: A Comparative Analysis of PS-SCL Recognition by a Single Tumor-reactive CD8+ Cytolytic T-Lymphocyte Clone
Cancer Res.,
April 1, 2002;
62(7):
2058 - 2063.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|